Company / Capital Expenditures
GERON CORP Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$680.0K
FY2024
5-year range
$16.0K / $830.0K
FY2020-FY2024
Trend
-18.1%
vs FY2023
Sector context
#129 of 194
Health Care
What the data says
At $680,000, GERON CORP's capital expenditures ranks #129 of 194 in the Health Care sector. Improved from $431,000 to $680,000 over the past 2 years.
Based on SEC 10-K filings.
$680,000 in FY2024 with a 5-year CAGR of +111.7%.
Improved from $431,000 to $680,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +18.1%
- 5-Year CAGR
- +111.7%
- 10-Year CAGR
- -
Sector benchmark
#129 of 194 in Health CareTop 66% of 194This company $680.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +111.7%, indicating consistent growth.
- In FY2024, capital expenditures decreased 18.1% year-over-year.
- Ranks #129 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $680.0K | -18.1% |
| FY2023 | $830.0K | +92.6% |
| FY2022 | $431.0K | +4.4% |
| FY2021 | $413.0K | +2481.3% |
| FY2020 | $16.0K | +0.0% |
| FY2019 | $16.0K | -71.9% |
| FY2018 | $57.0K | -36.7% |
| FY2017 | $90.0K | -31.3% |
| FY2016 | $131.0K | +4266.7% |
| FY2015 | $3.0K | -99.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026